Understanding Machine Learning Explainability Models in the context of Pancreatic Cancer Treatment
- José Bobes Bascarán 1
- Ángel Fernández Leal 1
- Eduardo Mosqueira Rey 1
- David Alonso Ríos 1
- Elena Hernández Pereira 1
- Vicente Moret Bonillo
-
1
Universidade da Coruña
info
- Manuel Lagos Rodríguez (ed. lit.)
- Álvaro Leitao Rodríguez (ed. lit.)
- Tirso Varela Rodeiro (ed. lit.)
- Javier Pereira Loureiro (coord.)
- Manuel Francisco González Penedo (coord.)
Editorial: Servizo de Publicacións ; Universidade da Coruña
Año de publicación: 2023
Congreso: XoveTIC (6. 2023. A Coruña)
Tipo: Aportación congreso
Resumen
The increasing adoption of artificial intelligent systems at sensitive domains where humans are particularly, such as medicine, has provided the context to deeply explore ways of making machine learning models (ML) understandable for their final users. The success of such systems require the trust of their users, and thus there is a need to design and provide methods to understand the decisions made by such systems. We start from a public Pancreatic Cancer dataset and experiment with different ML models on a diagnosis scenario with the goal to decide whether a patient should be prescribed with a chemotherapy treatment. To validate the diagnosis results we explore different explainability approaches: Decision Tree, Random Forest, and model agnostic ad-hoc models, and compare them against a standard Pancreatic Cancer treatment set of rules. The increasing adoption of artificial intelligent systems at sensitive domains where humans are particularly, such as medicine, has provided the context to deeply explore ways of making machine learning models (ML) understandable for their final users. The success of such systems require the trust of their users, and thus there is a need to design and provide methods to understand the decisions made by such systems. We start from a public Pancreatic Cancer dataset and experiment with different ML models. To validate the diagnostic results we explore different explainability approaches: Decision Tree based approach, Random Forest based approach, and different model agnostic ad-hoc approaches, and we compare them against a standard Pancreatic Cancer treatment set of rules